Miromatrix Medical Relocates to Glencoe
November 1, 2011
Pictured from left to right: Jeff Ross, Miromatrix Medical; Dave Theis, Midwest Porcine Recovery; and Robert Cohen, Miromatrix Medical.
GLENCOE, MN – October 28, 2011 – Miromatrix Medical Inc., a regenerative medicine company, unveiled their new research laboratory in Glencoe’s industrial park on Thursday, October 27th. The company is engaged in the development of commercial products, based upon its perfusion decellularization/recellularization technology licensed from the University of Minnesota.
The Miromatrix Medical technology has the potential to enable the creation of fully biological replacement organs for the human body. In addition to the company’s internal efforts focused on the development of its first product, a biomesh for hernia repair and breast reconstruction, scientists around the globe are working with the company’s technology and are taking the first steps toward the creation of human organs including the liver, lung, kidney, pancreas, and heart.
Miromatrix has enjoyed significant support and cooperation from both the State of Minnesota and the University of Minnesota. The City of Glencoe recently joined this list of supporters by attracting the Company to its industrial park, where Miromatrix will move into a new laboratory constructed to its specifications within the facility of one of its primary suppliers.